Cryotherapy, laser therapy, and intravitreal anti-vascular endothelial growth factor (VEGF) injection are the current treatments for ROP; however, they may induce the risk of ocular and systemic side effects [11]. The gene discussed is VEGFA; the disease is retinopathy of prematurity.